The Japanese investment holding company SoftBank Group (OTCPK:SFTBY) purchased two new stakes: 20.45M shares in Pacific Biosciences of California (PACB), and 14.66M shares in Recursion Pharmaceuticals ...

SoftBank disclosed a 20.45M share position in PacBio (PACB) and 14.67M share position in Recursion Pharmaceuticals (RXRX) in a regulatory ...

We recently compiled a list of the 10 Best Momentum Stocks to Buy According to Hedge Funds. In this article, we are going to ...

SoftBank’s AI investments face increasing risks, especially in OpenAI and Stargate. Find out why SFTBF stock could be ...

A pillar of the UK AI Opportunities Action Plan is lowering the barriers to constructing billions of pounds in new data ...

While market sentiments among SoftBank investors remain pessimistic due to the emergence of more low-cost alternatives from China, there is still hope.

Despite the tariff and DeepSeek turmoil, the U.S. stock market has been going strong in 2025, with the benchmark S&P 500 ...

SoftBank Group Corp. reported an earnings per share of -1.62, missing the estimated 1.91, reflecting financial struggles due ...

OpenAI has announced that Stargate, the massive AI infrastructure project recently unveiled by Trump, has broken ground in ...

1) The IPO and sell-down of the core Japanese telecom business. SoftBank sold around 36% of its shares of the core domestic telecom business in 2018 in an IPO, with the proceeds being used for ...

SoftBank reported a net loss of nearly $2.4 billion for its fiscal third quarter, with another quarter in the red for its ...

The report came just weeks after SoftBank chief Son appeared with President Trump and Sam Altman to announce the Stargate AI ...